View in EDS HTML Full Text PDF Full Text

Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.

Saved in:
Bibliographic Details
Title: Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
Authors: Ali A; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States., Barlow WE; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States., Moore HCF; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States., Hobday TJ; Division of Hematology and Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, United States., Isaacs C; Division of Hematology and Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, United States., Salim M; Division of Oncology, Allan Blair Cancer Center, Regina, Saskatchewan, Canada., Albain KS; Division of Hematology and Oncology, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, United States., Chew HK; Division of Hematology and Oncology, University of California-Davis Comprehensive Cancer Center, Sacramento, CA, United States., Burton GV; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, LA, United States., Srkalovic G; Division of Hematology and Oncology, University of Michigan Health - Sparrow, Herbert-Herman Cancer Center, Lansing, MI, United States., McGregor BA; Dvision of Hematology and Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Flaherty LE; Division of Hematology and Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, United States., Lew DL; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States., Gralow JR; American Society of Clinical Oncology Association for Clinical Oncology, Alexandria, VA, United States., Hortobagyi GN; Division of Hematology and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sharma P; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, United States., Pusztai L; Division of Hematology and Oncology, Yale Cancer Center, New Haven, CT, United States., Budd GT; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States.
Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2026 Mar 03; Vol. 10 (2).
Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41832961
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ali+A%22">Ali A</searchLink>; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Barlow+WE%22">Barlow WE</searchLink>; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Moore+HCF%22">Moore HCF</searchLink>; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Hobday+TJ%22">Hobday TJ</searchLink>; Division of Hematology and Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Division of Hematology and Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Salim+M%22">Salim M</searchLink>; Division of Oncology, Allan Blair Cancer Center, Regina, Saskatchewan, Canada.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Division of Hematology and Oncology, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Chew+HK%22">Chew HK</searchLink>; Division of Hematology and Oncology, University of California-Davis Comprehensive Cancer Center, Sacramento, CA, United States.<br /><searchLink fieldCode="AU" term="%22Burton+GV%22">Burton GV</searchLink>; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, LA, United States.<br /><searchLink fieldCode="AU" term="%22Srkalovic+G%22">Srkalovic G</searchLink>; Division of Hematology and Oncology, University of Michigan Health - Sparrow, Herbert-Herman Cancer Center, Lansing, MI, United States.<br /><searchLink fieldCode="AU" term="%22McGregor+BA%22">McGregor BA</searchLink>; Dvision of Hematology and Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Flaherty+LE%22">Flaherty LE</searchLink>; Division of Hematology and Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, United States.<br /><searchLink fieldCode="AU" term="%22Lew+DL%22">Lew DL</searchLink>; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Gralow+JR%22">Gralow JR</searchLink>; American Society of Clinical Oncology Association for Clinical Oncology, Alexandria, VA, United States.<br /><searchLink fieldCode="AU" term="%22Hortobagyi+GN%22">Hortobagyi GN</searchLink>; Division of Hematology and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, United States.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Division of Hematology and Oncology, Yale Cancer Center, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Budd+GT%22">Budd GT</searchLink>; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101721827%22">JNCI cancer spectrum</searchLink> [JNCI Cancer Spectr] 2026 Mar 03; Vol. 10 (2).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101721827 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2515-5091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225155091%22">25155091 </searchLink><i>NLM ISO Abbreviation: </i>JNCI Cancer Spectr <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41832961
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jncics/pkag024
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ali A
      – PersonEntity:
          Name:
            NameFull: Barlow WE
      – PersonEntity:
          Name:
            NameFull: Moore HCF
      – PersonEntity:
          Name:
            NameFull: Hobday TJ
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Salim M
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Chew HK
      – PersonEntity:
          Name:
            NameFull: Burton GV
      – PersonEntity:
          Name:
            NameFull: Srkalovic G
      – PersonEntity:
          Name:
            NameFull: McGregor BA
      – PersonEntity:
          Name:
            NameFull: Flaherty LE
      – PersonEntity:
          Name:
            NameFull: Lew DL
      – PersonEntity:
          Name:
            NameFull: Gralow JR
      – PersonEntity:
          Name:
            NameFull: Hortobagyi GN
      – PersonEntity:
          Name:
            NameFull: Sharma P
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Budd GT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2026 Mar 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2515-5091
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: JNCI cancer spectrum
              Type: main
ResultId 1